Trials / Terminated
TerminatedNCT03485651
Natera Ovarian Cancer Detection Assay
Prospective Collection of Samples for Development of the Natera Ovarian Cancer Detection Assay
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Natera, Inc. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to enroll participants who present with an adnexal mass on imaging to develop a non-invasive ovarian cancer assay to distinguish between malignant and benign masses. The study will collect blood, tissue, and health information from these individuals.
Conditions
Timeline
- Start date
- 2017-12-14
- Primary completion
- 2019-11-01
- Completion
- 2019-12-31
- First posted
- 2018-04-02
- Last updated
- 2020-02-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03485651. Inclusion in this directory is not an endorsement.